February 25, 2021

New anti-AB vaccine could help halt Alzheimer’s progression, preclinical study finds

A preclinical study by neuroscientists indicates that an antigen-presenting dendritic vaccine with a specific antibody response to oligomeric A-beta may be safer and offer clinical benefit in treating Alzheimer’s disease. The vaccine uses immune cells known as dendritic cells loaded with a modified A beta peptide as the antigen.

 Alzheimer’s Research News — ScienceDaily

 Read More

Leave a Reply

%d bloggers like this: